respiratory program (Pieris Pharmaceuticals/AstraZeneca)

N/A

Report date: 2025/01/26 16:20:09
NME

Base Information

Drug Namerespiratory program (Pieris Pharmaceuticals/AstraZeneca)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPieris Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcPieris Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A